Results 231 to 240 of about 731,610 (274)
Some of the next articles are maybe not open access.

Human platelet vasopressin receptors

Life Sciences, 1982
Specific saturable binding of 125I-arginine-vasopressin to human platelets is described. For ten normal volunteers the mean (+/- S.D.) KD is 5.6 nM (+/- 2.1) and the mean (+/- S.D.) Bmax is 115 fmoles/mg protein (+/- 30). Association studies indicate that equilibrium is reached after 90 minutes on ice.
W H, Berrettini   +3 more
openaire   +2 more sources

V2 vasopressin receptor mutations

2020
V2 vasopressin receptor (V2R) is a member of the G protein-coupled receptor (GPCR) family in which many disease-causing mutations have been identified and thus generated much interest. Loss-of-function V2R mutations cause nephrogenic diabetes insipidus (NDI) whereas gain-of-function mutations cause nephrogenic syndrome of inappropriate antidiuresis ...
Noriko, Makita   +3 more
openaire   +2 more sources

Vasopressin Receptors in Voiding Dysfunction

2011
Arginine vasopressin (AVP), also known as vasopressin or anti-diuretic hormone, is a neuropeptide produced in the hypothalamus. It is primarily responsible for osmoregulation and thus maintains body fluid homeostasis. It is also a potent vasoconstrictor, may have a role in higher cognitive functions and affects metabolism.
Sailaja, Pisipati, Hashim, Hashim
openaire   +2 more sources

Human vascular vasopressin receptors: analysis with selective vasopressin receptor antagonists.

The Journal of Pharmacology and Experimental Therapeutics, 1986
The vascular activity of arginine vasopressin (AVP) and selective AVP receptor antagonists was investigated in isolated arterial ring segments from human superior mesenteric arteries. AVP elicited a potent and concentration-dependent contraction in human mesenteric arterial rings with an EC50 value of 2.01 X 10(-9) M.
E H, Ohlstein, B A, Berkowitz
openaire   +2 more sources

Vasopressin: Mechanisms of Receptor Activation

1983
Publisher Summary Vasopressin exerts a large variety of biological effects such as increased glycogenolysis and neoglucogenesis by liver cells and increased corticotrophin release by the adenohypophysis. This chapter presents an overview of the available pharmacological and biochemical data on vasopressin receptors in mammals.
openaire   +2 more sources

Novel vasopressin receptor ligands

Biochemical Society Transactions, 1991
J, Howl, I, Kerr, C H, Chan, M, Wheatley
openaire   +2 more sources

Vasopressin in Affective Illness.

Lancet, The, 1978
Victor I Reus   +2 more
exaly  

Vasopressin: A First-Line Agent for Septic Shock?

Nature Reviews Nephrology, 2016
Jean-Louis Vincent
exaly  

Home - About - Disclaimer - Privacy